149 related articles for article (PubMed ID: 36564674)
1. External validation of FRISBEE 5-year fracture prediction models: a registry-based cohort study.
Agarwal A; Baleanu F; Moreau M; Charles A; Iconaru L; Surquin M; Benoit F; Paesmans M; Karmali R; Bergmann P; Body JJ; Leslie WD
Arch Osteoporos; 2022 Dec; 18(1):13. PubMed ID: 36564674
[TBL] [Abstract][Full Text] [Related]
2. Predictive performance of the Garvan Fracture Risk Calculator: a registry-based cohort study.
Agarwal A; Leslie WD; Nguyen TV; Morin SN; Lix LM; Eisman JA
Osteoporos Int; 2022 Mar; 33(3):541-548. PubMed ID: 34839377
[TBL] [Abstract][Full Text] [Related]
3. Prediction of an Imminent Fracture After an Index Fracture - Models Derived From the Frisbee Cohort.
Iconaru L; Charles A; Baleanu F; Surquin M; Benoit F; Mugisha A; Moreau M; Paesmans M; Karmali R; Rubinstein M; Rozenberg S; Body JJ; Bergmann P
J Bone Miner Res; 2022 Jan; 37(1):59-67. PubMed ID: 34490908
[TBL] [Abstract][Full Text] [Related]
4. Prediction of imminent fracture risk in Canadian women and men aged 45 years or older: external validation of the Fracture Risk Evaluation Model (FREM).
Möller S; Skjødt MK; Yan L; Abrahamsen B; Lix LM; McCloskey EV; Johansson H; Harvey NC; Kanis JA; Rubin KH; Leslie WD
Osteoporos Int; 2022 Jan; 33(1):57-66. PubMed ID: 34596704
[TBL] [Abstract][Full Text] [Related]
5. Fragility Fractures in Postmenopausal Women: Development of 5-Year Prediction Models Using the FRISBEE Study.
Baleanu F; Moreau M; Charles A; Iconaru L; Karmali R; Surquin M; Benoit F; Mugisha A; Paesmans M; Rubinstein M; Rozenberg S; Bergmann P; Body JJ
J Clin Endocrinol Metab; 2022 May; 107(6):e2438-e2448. PubMed ID: 35176768
[TBL] [Abstract][Full Text] [Related]
6. Independent External Validation of FRAX and Garvan Fracture Risk Calculators: A Sub-Study of the FRISBEE Cohort.
Baleanu F; Iconaru L; Charles A; Kinnard V; Fils JF; Moreau M; Karmali R; Surquin M; Benoit F; Mugisha A; Paesmans M; Laurent MR; Bergmann P; Body JJ
JBMR Plus; 2021 Sep; 5(9):e10532. PubMed ID: 34532617
[TBL] [Abstract][Full Text] [Related]
7. Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos.
Fraser LA; Langsetmo L; Berger C; Ioannidis G; Goltzman D; Adachi JD; Papaioannou A; Josse R; Kovacs CS; Olszynski WP; Towheed T; Hanley DA; Kaiser SM; Prior J; Jamal S; Kreiger N; Brown JP; Johansson H; Oden A; McCloskey E; Kanis JA; Leslie WD;
Osteoporos Int; 2011 Mar; 22(3):829-37. PubMed ID: 21161508
[TBL] [Abstract][Full Text] [Related]
8. FRAX provides robust fracture prediction regardless of socioeconomic status.
Brennan SL; Leslie WD; Lix LM; Johansson H; Oden A; McCloskey E; Kanis JA
Osteoporos Int; 2014 Jan; 25(1):61-9. PubMed ID: 24190425
[TBL] [Abstract][Full Text] [Related]
9. FRAX for fracture prediction shorter and longer than 10 years: the Manitoba BMD registry.
Leslie WD; Majumdar SR; Morin SN; Lix LM; Johansson H; Oden A; McCloskey EV; Kanis JA
Osteoporos Int; 2017 Sep; 28(9):2557-2564. PubMed ID: 28593449
[TBL] [Abstract][Full Text] [Related]
10. Performance of FRAX in Men With Prostate Cancer: A Registry-Based Cohort Study.
Ye C; Morin SN; Lix LM; McCloskey EV; Johansson H; Harvey NC; Kanis JA; Leslie WD
J Bone Miner Res; 2023 May; 38(5):659-664. PubMed ID: 36807916
[TBL] [Abstract][Full Text] [Related]
11. Underevaluation of fractures by self-report: an analysis from the FRISBEE cohort.
Baleanu F; Moreau M; Kinnard V; Iconaru L; Karmali R; Rozenberg S; Rubinstein M; Paesmans M; Bergmann P; Body JJ
Arch Osteoporos; 2020 Apr; 15(1):61. PubMed ID: 32323006
[TBL] [Abstract][Full Text] [Related]
12. Adjusting FRAX Estimates of Fracture Probability Based on a Positive Vertebral Fracture Assessment.
Ye C; Leslie WD; Morin SN; Lix LM; McCloskey EV; Johansson H; Harvey NC; Lorentzon M; Kanis JA
JAMA Netw Open; 2023 Aug; 6(8):e2329253. PubMed ID: 37589976
[TBL] [Abstract][Full Text] [Related]
13. Fracture Risk Indices From DXA-Based Finite Element Analysis Predict Incident Fractures Independently From FRAX: The Manitoba BMD Registry.
Leslie WD; Luo Y; Yang S; Goertzen AL; Ahmed S; Delubac I; Lix LM
J Clin Densitom; 2019; 22(3):338-345. PubMed ID: 30852033
[TBL] [Abstract][Full Text] [Related]
14. Direct comparison of eight national FRAX® tools for fracture prediction and treatment qualification in Canadian women.
Leslie WD; Brennan SL; Lix LM; Johansson H; Oden A; McCloskey E; Kanis JA
Arch Osteoporos; 2013; 8():145. PubMed ID: 23929269
[TBL] [Abstract][Full Text] [Related]
15. MOF/Hip Fracture Ratio in a Belgian Cohort of Post-menopausal Women (FRISBEE): Potential Impact on the FRAX® Score.
Mugisha A; Bergmann P; Kinnard V; Iconaru L; Baleanu F; Charles A; Surquin M; Rozenberg S; Benoit F; Body JJ
Calcif Tissue Int; 2021 Dec; 109(6):600-604. PubMed ID: 34159447
[TBL] [Abstract][Full Text] [Related]
16. Fracture prediction from FRAX for Canadian ethnic groups: a registry-based cohort study.
Leslie WD; Morin SN; Lix LM; McCloskey EV; Johansson H; Harvey NC; Kanis JA
Osteoporos Int; 2021 Jan; 32(1):113-122. PubMed ID: 32809043
[TBL] [Abstract][Full Text] [Related]
17. Fracture prediction from self-reported falls in routine clinical practice: a registry-based cohort study.
Leslie WD; Morin SN; Lix LM; Martineau P; Bryanton M; McCloskey EV; Johansson H; Harvey NC; Kanis JA
Osteoporos Int; 2019 Nov; 30(11):2195-2203. PubMed ID: 31372711
[TBL] [Abstract][Full Text] [Related]
18. Selection for treatment of patients at high risk of fracture by the short versus long term prediction models - data from the Belgian FRISBEE cohort.
Iconaru L; Charles A; Baleanu F; Moreau M; Surquin M; Benoit F; de Filette J; Karmali R; Body JJ; Bergmann P
Osteoporos Int; 2023 Jun; 34(6):1119-1125. PubMed ID: 37022466
[TBL] [Abstract][Full Text] [Related]
19. Osteoporosis treatment considerations based upon fracture history, fracture risk assessment, vertebral fracture assessment, and bone density in Canada.
Leslie WD; Lix LM; Binkley N
Arch Osteoporos; 2020 Jun; 15(1):93. PubMed ID: 32577922
[TBL] [Abstract][Full Text] [Related]
20. Which is the preferred site for bone mineral density monitoring as an indicator of treatment-related anti-fracture effect in routine clinical practice? A registry-based cohort study.
Leslie WD; Martineau P; Bryanton M; Lix LM
Osteoporos Int; 2019 Jul; 30(7):1445-1453. PubMed ID: 31016351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
